Tsunehisa SATO

Dr. Tsunehisa SATO

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2018 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
KKKensuke Kobayashi
Kensuke Kobayashi
SMSoichiro Mimuro
Soichiro Mimuro
TSTsunehisa SATO
Tsunehisa SATO
AKAtsushi Kobayashi
Atsushi Kobayashi
SKShingo Kawashima
Shingo Kawashima
YNYoshiki Nakajima
Yoshiki Nakajima

10 July 2016 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
SKShingo Kawashima
Shingo Kawashima
YSYuji Suzuki
Yuji Suzuki
TSTsunehisa SATO
Tsunehisa SATO
MKMutsuhito Kikura
Mutsuhito Kikura
TKTakasumi Katoh
Takasumi Katoh
SSShigehito Sato
Shigehito Sato
Fibrinogen and fibrin formation have a key role in perioperative hemostasis. The aim of this study is to examine the association of postoperative hemostasis with a combined evaluation of the fibrinogen level and fibrin polymerization in cardiac surgery. We retrospectively classified 215 consecutive cardiac surgery patients into 4 groups (Fuji-san classification) that were divided by fibrinogen level <150 mg/dL (ie, hypofibrinogenemia) and fibrinogen thromboelastometry value at 10 minutes with rotational thromboelastometry <6 mm (ie, low fibrin polymerization) at the warming of cardiopulmonary bypass. Four groups resulted; group I, the acceptable range (n = 85); group II, only hypofibrinogenemia (<150 mg/dL, ≥6 mm, n = 63); group III, hypofibrinogenemia and low fibrin polymerization (<150 mg/dL, <6 mm, n = 60); and group IV, only low fibrin polymerization (≥150 mg/dL, <6 mm, n = 7). The risk of chest tube drainage volume greater than 500 mL within the first 24 hours after surgery (with group I as the reference) was increased in group II (odds ratio [OR], 3.3; 95% confidence interval [CI], 1.5-7.4; P < .01) and group III (OR, 8.5; 95% CI, 3.5-21.7; P < .01), and the risk greater than 1000 mL (with group I as the reference) was increased in group III (OR, 4.0; 95% CI, 1.1-17.3; P = .03) and group IV (OR, 23.1; 95% CI, 3.2-201.0; P < .01). Intraoperative blood transfusions were decreased by 24.5%, after stratifying the starting amount of fresh frozen plasma by the 4-group classification in the recent consecutive 65 (30.2%) patients (P < .01). The 4-group classification is associated with postoperative bleeding and may improve the quality of perioperative blood transfusion in cardiac surgery.

30 January 2020 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
TSTsunehisa SATO
Tsunehisa SATO
SMSoichiro Mimuro
Soichiro Mimuro
TKTakasumi Katoh
Takasumi Katoh
TKTadayoshi Kurita
Tadayoshi Kurita
STSang Kien Truong
Sang Kien Truong
YNYoshiki Nakajima
Yoshiki Nakajima

1 January 2015
Verified
Journal Article
Closed access
MKMutsuhito Kikura
Mutsuhito Kikura
YSYuji Suzuki
Yuji Suzuki
TITaiga Itagaki
Taiga Itagaki
TSTsunehisa SATO
Tsunehisa SATO
JNJunko Nishino
Junko Nishino

19 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HIHiroki Iwata
Hiroki Iwata
TKTakasumi Katoh
Takasumi Katoh
STSang Kien Truong
Sang Kien Truong
TSTsunehisa SATO
Tsunehisa SATO
SKShingo Kawashima
Shingo Kawashima
YNYoshiki Nakajima
Yoshiki Nakajima
Cardiopulmonary bypass (CPB) causes systemic inflammation and endothelial glycocalyx damage. Hydrogen has anti-oxidant and anti-inflammatory properties; therefore, we hypothesized that hydrogen would alleviate endothelial glycocalyx damage caused by CPB. Twenty-eight male Sprague–Dawley rats were randomly divided into four groups (n = 7 per group), as follows: sham, control, 2% hydrogen, and 4% hydrogen. The rats were subjected to 90 minutes of partial CPB followed by 120 minutes of observation. In the hydrogen groups, hydrogen was administered via the ventilator and artificial lung during CPB, and via the ventilator for 60 minutes after CPB. After observation, blood collection, lung extraction, and perfusion fixation were performed, and the heart, lung, and brain endothelial glycocalyx thickness was measured by electron microscopy. The serum syndecan-1 concentration, a glycocalyx component, in the 4% hydrogen group (5.7 ± 4.4 pg/mL) was lower than in the control (19.5 ± 6.6 pg/mL) and 2% hydrogen (19.8 ± 5.0 pg/mL) groups (P < 0.001 for each), but it was not significantly different from the sham group (6.2 ± 4.0 pg/mL, P = 0.999). The endothelial glycocalyces of the heart and lung in the 4% hydrogen group were thicker than in the control group. The 4% hydrogen group had lower inflammatory cytokine concentrations (interleukin-1β and tumor necrosis factor-α) in serum and lung tissue, as well as a lower serum malondialdehyde concentration, than the control group. The 2% hydrogen group showed no significant difference in the serum syndecan-1 concentration compared with the control group. However, non-significant decreases in serum and lung tissue inflammatory cytokine concentrations, as well as in serum malondialdehyde concentration, were observed. Administration of 4% hydrogen via artificial and autologous lungs attenuated endothelial glycocalyx damage caused by partial CPB in rats, which might be mediated by the anti-inflammatory and anti-oxidant properties of hydrogen.

1 December 2021 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
MKMutsuhito Kikura
Mutsuhito Kikura
YSYuji Suzuki
Yuji Suzuki
TSTsunehisa SATO
Tsunehisa SATO
MUMasahiro Uraoka
Masahiro Uraoka
SKShingo Kawashima
Shingo Kawashima